abstract |
The present invention relates to quinazolinone compounds useful for the treatment of cell proliferative diseases, the treatment of disorders associated with KSP kinesin activity, and the inhibition of KSP kinesin. The invention also relates to compositions containing these compounds and their use in the treatment of cancer in mammals. |